Flaraxin

FLARAXIN IS EFFECTIVE WHIT 90 % OF ONCOLOGIC DISEASES 

Brain cancer, melanoblastoma, breast, lung cancer, mammary gland cancer, ovaries cancer, neck of womb cancer, womb cancer, prostate gland cancer, sigmoid and rectum cancer, stomach cancer, bladder cancer which are equivalent to 90% of a total quantity of oncologic diseases. FLARAXIN is most effective in the cases of the small tumor defeats, when vital organs (liver, kidneys) are not defeated. In these cases the complete response (CR or reduction) of tumor can be reached.Flaraxin application efficiency in different cases with cancer.
FLARAXIN is a remedy of vegetable origin a non-toxic anti-tumoral phytopreparation, having neither allergenic nor local irritative activity, interferonogene, stimulating tumoral necrosis factor, destroys tumoral  tissue. Immunomodulator and antioxidant. Prevents metastatic spreading and relapse.FLARAXIN is most effective in the cases of the small tumor defeats, when vital organs (liver, kidneys) are not defeated. In these cases the complete response (CR or reduction) of tumor can be reached.Flaraxin is worked out in Scientific & Treatment Center for Cancer
Curing "PHOENIX" (License of the Ukrainian Ministry of Health Seria АБ No.299302) allow to realize effective treatment of the patients, not to be treated by traditional methods 
 
INFORMATION ABOUT STCCC PHOENIX

STCCC Phoenix founded in 1996 to coordinate research work on a comprehensive study of a new anticancer drugs of plant origin -FLARAXIN (historical background), which was developed in the Kiev Research Institute of Pharmacology and Toxicology by the surgical oncologists Kulik Ivan Anisimovich.
STCCC Phoenix developed and clinically tested a number of biologically active preparations of plant origin. For the first time, has been used a unique technology of plant concentrates, allowing several times to increase the biological activity of number natural substances.
As a result of comprehensive research has developed a number of medical treatments for cancer patients by the FLARAXIN together with a number of biologically active preparations.
The practice of their application showed the effectiveness of their impact on a number of infectious, virus, somatic and cancer diseases.
For early detection of cancer, as well as possible recurrence introduced the latest techniques of early detection. The method of professor Shahbazov predicts the impact of a drug to identify pathology.
Now medications of STCCC "Phoenix" are used, as in oncology clinics, and medical centers of Ukraineand Russia.
 
PRIORITIES OF THE CENTER
 
Optimization of the existing methods of treatment for cancer patients combining the use of surgery, chemotherapy and radiotherapy and FLARAXIN in various combinations.
Application of our medications for the profilactics and prevention of recidivation, after medical investigation and ascertainment of diathesis to tumors.
The prevention and elimination of possible recurrence of the disease.
Consultation of the patients about non-toxic treatment of tumors.
Provide scientific and technical assistance to a wide range of health professionals on the practical application of biologically active drugs in the treatment of infectious parasitic disease, somatic and cancerpathology.
The research, development and clinical testing of new drugs of vegetable origin derived from the vacuum-condensing and drying technology.

STCCC PHOENIX www.flaraxin.com ore SCIENTIFIC & TREATMENT CENTER FOR CANCER CURING PHOENIX 
 
National University of Pharmacy (NUPh) of Ukraine http://www.pharm.kharkiv.edu/
 
Kharkiv Medical Academy of Postgraduate Education http://med.edu.ua/en
 
Filatov Institute of eye diseases and tissue AMS of Ukraine http://www.filatov.md/eng/
 
Do further research yourself !
 
BACK TO MAIN PAGE : CANCER IS CURABLE
 
Comments